Keeren Shah
Chief Financial OfficerMs. Keeren Shah serves as Chief Financial Officer at Tiziana Life Sciences Ltd since 2022 and serves as its Chief Operating Officer since 2024 and served as Finance Director until 2022. She serves as Chief Financial Officer at OKYO Pharma Limited since August 2020. She serves as Chief Financial Officer at Actavia Life Sciences, Inc. (formerly known as Rasna Therapeutics, Inc) since July 2020 and served as its Finance Director since July 31, 2020 & Financial Controller from July 2016 until July 2020. Ms. Shah has been the Finance Director of Tiziana Life Sciences since August 2020. She is Chief Financial Officer at AccuStem Sciences Limited since August 2021. She is the Chief Financial Officer of Accustem Sciences, Inc. since August 2021. Ms. Shah spent at Visa, Inc. as a Senior Leader in its finance team where she was responsible for key financial controller activities, financial planning and analysis and core processes as well as leading and participating in key transformation programmes and Visa Inc.’s initial public offering. Before joining Visa, Ms. Shah has also held a variety of finance positions at other leading companies including Arthur Andersen and BBC Worldwide. She holds a Bachelor of arts with honors in Economics and is a member of the Chartered Institute of Management Accountants.
Positions
- Company NameOKYO Pharma LimitedStock CodeOKYOPositionChief Financial OfficerColleagues
- RJRobert J. DempseyCEO & Executive Director
- GMGabriele Marco Antonio CerroneNon-Executive Chairman
- KSKeeren ShahChief Financial Officer
- RPRajkumar PatilChief Scientific Officer
- GSGary S. JacobChief Development Officer & Director
- FMFlavio MantelliChief Medical Officer
- WJWilly Jules SimonSenior Independent Non-Executive Director
- JPJohn Patrick BrancaccioIndependent Non-Executive Director
- Company NameTiziana Life Sciences LtdStock CodeTLSAPositionCOO & CFOColleagues
- GMGabriele Marco Antonio CerroneFounder & Executive Chairman
- IRIvor R. ElrifiCEO & Executive Director
- WEWilliam Edward TenteChief Regulatory Officer
- RKRichard K. KimChief Medical Officer
- NFNapoleone FerraraMember of Scientific Advisory Board
- WJWilly Jules SimonIndependent Non-Executive Director
- JPJohn Patrick BrancaccioIndependent Non-Executive Director
- Company NameAccuStem Sciences, Inc.Stock CodeACUTPositionChief Financial OfficerColleagues
- GMGabriele Marco Antonio CerroneExecutive Chairman of the Board
- WEWendy E. BlosserCEO & Director
- JFJeff FenstererChief Operating Officer
- JFJoe FlanaganChief Business Officer
- KSKeeren ShahChief Financial Officer
- JPJohn Patrick BrancaccioIndependent Director
- WJWilly Jules SimonIndependent Director
- SCSean C. McDonaldDirector
